NEW YORK, June 15 (GenomeWeb News) - Lansing Taylor, co-founder of Cellomics and the Pittsburgh Life Sciences Greenhouse, has founded a new company, Cellumen, the company said yesterday in its maiden announcement.
Cellumen, will initially will be headquarted at the PLSG's incubator and will form drug discovery collaborations with pharmaceutical and biotechnology companies using High-Content Screening, a cell-based screening method developed by Cellomics.
Taylor joined with Alan Waggoner from Carnegie Mellon University, who has had a hand in creating other life sciences technologies with Taylor. Taylor and Kenneth Giuliano, a scientist, will be Cellumen's first two employees. The company expects to have a total staff of five to six employees by the end of its first year of operation.